Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
The combination of loss of glyoxalase1 and obesity results in hyperglycemia
Elisabeth Lodd, Lucas M. Wiggenhauser, Jakob Morgenstern, Thomas H. Fleming, Gernot Poschet, Michael Büttner, Christoph T. Tabler, David P. Wohlfart, Peter P. Nawroth, Jens Kroll
Elisabeth Lodd, Lucas M. Wiggenhauser, Jakob Morgenstern, Thomas H. Fleming, Gernot Poschet, Michael Büttner, Christoph T. Tabler, David P. Wohlfart, Peter P. Nawroth, Jens Kroll
View: Text | PDF
Research Article Endocrinology Metabolism

The combination of loss of glyoxalase1 and obesity results in hyperglycemia

  • Text
  • PDF
Abstract

The increased formation of methylglyoxal (MG) under hyperglycemia is associated with the development of microvascular complications in patients with diabetes mellitus; however, the effects of elevated MG levels in vivo are poorly understood. In zebrafish, a transient knockdown of glyoxalase 1, the main MG detoxifying system, led to the elevation of endogenous MG levels and blood vessel alterations. To evaluate effects of a permanent knockout of glyoxalase 1 in vivo, glo1–/– zebrafish mutants were generated using CRISPR/Cas9. In addition, a diet-induced–obesity zebrafish model was used to analyze glo1–/– zebrafish under high nutrient intake. Glo1–/– zebrafish survived until adulthood without growth deficit and showed increased tissue MG concentrations. Impaired glucose tolerance developed in adult glo1–/– zebrafish and was indicated by increased postprandial blood glucose levels and postprandial S6 kinase activation. Challenged by an overfeeding period, fasting blood glucose levels in glo1–/– zebrafish were increased which translated into retinal blood vessel alterations. Thus, the data have identified a defective MG detoxification as a metabolic prerequisite and glyoxalase 1 alterations as a genetic susceptibility to the development of type 2 diabetes mellitus under high nutrition intake.

Authors

Elisabeth Lodd, Lucas M. Wiggenhauser, Jakob Morgenstern, Thomas H. Fleming, Gernot Poschet, Michael Büttner, Christoph T. Tabler, David P. Wohlfart, Peter P. Nawroth, Jens Kroll

×

Figure 4

Altered fatty acid metabolism in glo1–/– zebrafish larvae.

Options: View larger image (or click on image) Download as PowerPoint
Altered fatty acid metabolism in glo1–/– zebrafish larvae.
(A–D) Omega-3...
(A–D) Omega-3 (A), omega-9 fatty acids (B), and saturated fatty acids (C and D) levels are increased in glo1–/– in comparison with glo1+/+ zebrafish larvae at 96 hpf. Whole zebrafish larvae lysates at 96 hpf were used for FAME-GC-MS analysis and results were normalized to percentage of C17:0, which was added before cell lysis; n = 3 clutches with 40–50 larvae; mean ± SEM. (E) Expression of fatty acid synthesis genes is not altered in glo1–/– in comparison with glo1+/+ larvae at 96 hpf. Expression of genes was determined by RT-qPCR and normalized to β actin. Values for glo1+/+ zebrafish embryos were standardized to 1, n = 3 clutches with 30–40 larvae; mean ± SEM. For statistical analysis Student’s t test was applied. *P < 0.05; **P < 0.01; ***P < 0.001. Fasn, fatty acid synthase; Fads2, fatty acid desaturase 2; Elovl2, fatty acid elongase 2; Scd, stearoyl-CoA desaturase; ns, not significant; C18:1n9t, elaidic acid methyl ester; C18:1n9c, oleic acid methyl ester; C16:0, palmitic acid methyl ester; C18:0, stearic acid methyl ester; C20:0, arachidic acid methyl ester; C22:0, behenic acid methyl ester; C24:0, lignoceric acid methyl ester; C20:5n3, cis-5,8,11,14,17-eicosapentaenoic acid methyl ester; C22:6n3, cis-4,7,10,13,16,19-docosahexaenoic acid methyl ester.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts